University of Cambridge > > Milner Therapeutics Institute > Milner Therapeutics Hybrid Symposium

Milner Therapeutics Hybrid Symposium

Add to your list(s) Download to your calendar using vCal

If you have a question about this talk, please contact ndo23.

Our Annual Symposium is an opportunity for scientists from academia and industry to discuss the latest academic and pre-clinical research and how it could be applied in the pharma and biotech industry to develop new treatments.

This will be our first ever Hybrid Symposium, where we will welcome up to 500 delegates in person and also live-stream the event for those who are overseas or unable to attend.

Registration to the Symposium is free, and is open to academics and Milner affiliated companies only.

Speakers: Simon Boulton (Artios Pharma and The Francis Crick Institute) Lori Passmore (MRC Laboratory of Molecular Biology) Ravindra Gupta (Cambridge Institute of Therapeutic Immunology and Infectious Disease) Kristian Helin (Institute of Cancer Research) Giulia Biffi (CRUK Cambridge Institute, University of Cambridge) Matthias Zilbauer (Department of Paediatrics, University of Cambridge) Richard Hargreaves (Bristol Myers Squibb) and Andras Lakatos (Centre for Brain Repair, Department of Clinical Neurosciences, University of Cambridge)

This talk is part of the Milner Therapeutics Institute series.

Tell a friend about this talk:

This talk is included in these lists:

Note that ex-directory lists are not shown.


© 2006-2023, University of Cambridge. Contact Us | Help and Documentation | Privacy and Publicity